CBD for Antibiotic Resistant Bacteria

CBD for Antibiotic Resistant Bacteria
CBD for Antibiotic Resistant Bacteria - https://ift.tt/2qwJBGv - PrimeMyBody's utilizes a unique liposomal delivery system, which dramatically improves the bioavailability of the oil. Our product is a Dietary Supplement and contains hemp extract derived from the stalks and stems of the mature industrial hemp plant, which delivers healthful benefits, without having the psychoactive or high effect associated with this type of botanical. CBD for Antibiotic Resistant Bacteria Cannabinoid receptors are found throughout the body, primarily in the immune system and the structures associated with healthy immune functioning. With these cannabinoid receptor sites spread throughout our entire bodies, it is paramount these receptors are working properly to keep this important internal system functioning to protect you. CBD for Antibiotic Resistant Bacteria PrimeMyBody's non detectable THC less than point three percent Phyto cannabinoid Diol hemp extract uses our cutting-edge liposomal delivery methods to increase absorption of this exceptional natural compound. CBD for Antibiotic Resistant Bacteria PrimeMyBody utilizes a unique liposomal delivery system, which dramatically improves bioavailability of the oil. Our product is a Dietary Supplement and contains industrial hemp extract derived from the stalks and stems of the hemp plant, which delivers healthful benefits, without the psychoactive or “high" effect associated with this type of botanical. CBD for Antibiotic Resistant Bacteria We recently conducted a 10 person, in-house study comparing Intra Absorption bio availability of Liposomal & Non-Liposomal Cannabidiol. Relative bioavailability is determined by comparing the plasma concentration time-curves (usually as area under the curve) after administration of two different formulations of the same compound. The results of the study revealed that PrimeMyBody's liposomal Nano-Enhanced Hemp Oil was absorbed into the blood in amounts almost 6 times greater than the non-liposomal formulation tested. The graph concludes that our liposomal hemp oil far out-performs the non-liposomal formulation. In this study, our CBD liposome formulation was tested against our CBD in hemp seed oil as a carrier. CBD for Antibiotic Resistant Bacteria Unlike other liposomal products using low grade phospholipids that breakdown and do not deliver compounds effectively, our high grade phosphatidylcholine phospholipids are smaller, more stable, single-layer spheres which maximize bioavialabilty of our hemp oil. With this study, it's easy to see how our liposomal formulation brings the power of intravenous therapy into convenient oral delivery for rapid uptake. Our vesicles are small enough to begin absorption as soon as they hit your mouth, it’s lightning fast! CBD for Antibiotic Resistant Bacteria Dr. Shade earned his P h D from University of Illinois studying the environmental and analytical chemistries of mercury and advanced aquatic chemistry. He has since developed specific analytical techniques for measuring mercury exposure and a system of products to remove metallic and organic toxins by upregulation of innate detoxification biochemistry. CBD for Antibiotic Resistant Bacteria via https://youtu.be/j8QW4sK413E